Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression | ACS Pharmacology & Translational Science
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy - Repository of the Academy's Library
![Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy | SpringerLink Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-020-02174-2/MediaObjects/702_2020_2174_Fig2_HTML.png)
Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy | SpringerLink
![IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines](https://www.mdpi.com/ijms/ijms-20-00426/article_deploy/html/images/ijms-20-00426-g002.png)
IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines
![IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines](https://www.mdpi.com/ijms/ijms-20-00426/article_deploy/html/images/ijms-20-00426-g001.png)
IJMS | Free Full-Text | Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines
![Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression | ACS Pharmacology & Translational Science Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00068/asset/images/large/pt9b00068_0003.jpeg)